ZIM LABORATORIES
ZIMLAB · NSE
136.29
-0.25 (-0.18%)
as of 30 Oct 2026 close
Open
134.63
High
137.89
Low
130.00
Prev close
136.54
52w high
159.81
12 Oct 2026
52w low
59.31
30 Mar 2026
VWAP
134.38
Delivery %
56.6%
of volume
Volume 77,430 · turnover ₹1.04 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 25 Nov 2022
- ISIN
- INE518E01015
- Series
- EQ
- Listed on NSE
- 25 Nov 2022
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 31 Oct 2026
Daily · NSE EOD
Shareholding · as of 30 Sept 2026
Promoters
30.30%
-0.06 pp QoQ
Public
69.70%
26-06
26-09
Promoter share by quarter · source: NSE shareholding filings (XBRL). DIIs include mutual funds and insurers.
Quarterly results · Standalone · latest 30 Jun 2026
filed 06 Aug 2026, 05:44 pm IST| ₹ crore | Jun 26* |
|---|---|
| Revenue | 93 |
| Other income | 1 |
| Total expenses | 99 |
| Operating margin | 2.6% |
| Finance costs | 4 |
| Depreciation | 5 |
| Profit before tax | -5 |
| Tax | -2 |
| Net profit | -4 |
| Net margin | -4.2% |
| EPS (₹) | -0.72 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison